Posted on 3/29/18
Forget Merck: Novavax, Inc. Is a Better Vaccine Stock
Could Novavax, Inc. (NASDAQ:NVAX) be a better vaccine stock than Merck (NYSE:MRK)? I think so.That might sound crazy. After all, Novavax is tiny and unproven. It's . . .
Posted on 3/28/18
MacroGenics Prices Public Offering of Common Stock
ROCKVILLE, MD, March 28, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the . . .
Posted on 3/27/18
Largest Kidney Patient Organization Joins Gout Alliance
The American Association of Kidney Patients (AAKP), America's largest independent and patient-lead kidney advocacy organization, announced its participation in The Alliance for Gout Awareness. AAKP has . . .
Posted on 3/26/18
MacroGenics Announces Proposed Public Offering of Common Stock
ROCKVILLE, MD, March 26, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for . . .
Posted on 3/26/18
Frost & Sullivan Names Appian Top 2018 Digital Transformation Platform in Life Sciences & Pharmaceuticals
RESTON, Va., March 26, 2018 (GLOBE NEWSWIRE) -- Appian (NASDAQ:APPN) received Frost & Sullivan’s 2018 North American Digital Transformation Platform award in the Life Sciences & . . .
Posted on 3/22/18
Dr. Verinder Nirankari Joins Katzen Eye Group
Katzen Eye Group, Maryland’s largest private eye care practice, announced that Verinder S. Nirankari, M.D. F.A.C.S. has
Posted on 3/22/18
Aziyo Biologics Expands Bone Repair Franchise with Launch of OsteGro
SILVER SPRING, Md.--(BUSINESS WIRE)--Aziyo Biologics, Inc., a fully integrated regenerative medicine company, announced today the launch of OsteGro, an allograft bone matrix that supports new bone . . .
Posted on 3/20/18
MellingMedical Awarded Federal Supply Contract for Pharmaceuticals
ALEXANDRIA, Va.--(BUSINESS WIRE)--MellingMedical, a licensed pharmaceutical wholesale distributor and verified Service Disabled Veteran Owned Small Business (SDVOSB), was recently awarded a Federal Supply Schedule 65IB Drugs, . . .
Posted on 3/20/18
CASI Pharmaceuticals Announces $50 Million Private Placement
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients, announces today a $50 . . .
Posted on 3/19/18
GlycoMimetics Announces Proposed Public Offering of Common Stock
ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC), a clinical-stage biotechnology company focused on the discovery and development of novel glycomimetic drugs, today announced that it intends to . . .
Posted on 3/19/18
MaSTherCell Appointed as Process Development and Manufacturing Partner for Zelluna Immunotherapy’s TCR Adoptive Cell Therapy Platform
GERMANTOWN, Md., March 19, 2018 (GLOBE NEWSWIRE) -- Orgenesis Inc. (Nasdaq:ORGS), a manufacturer, service provider and developer of advanced cell therapies, today announced that its manufacturing . . .
Posted on 3/16/18
Vanda Pharmaceuticals Prices Public Offering of Common Stock
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA)today announced the sale of 5,500,000 shares of its common stock in an underwritten public offering at a price to the . . .
Posted on 3/15/18
Care Progress Awarded National Cancer Institute SBIR Fast Track
BETHESDA, Md.--(BUSINESS WIRE)--Care Progress, LLC announced it has been awarded a National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Fast Track Contract. The award will . . .
Posted on 3/15/18
Supernus Prices $350 Million Private Offering
ROCKVILLE, Md., March 15, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of . . .
Posted on 3/15/18
Supernus Prices $350 Million Private Offering
ROCKVILLE, Md., March 15, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of . . .
Posted on 3/15/18
Novavax's (NVAX) CEO Stan Erck on Q4 2017 Results - Earnings Call Transcript
Novavax, Inc. (NASDAQ:NVAX) Q4 2017 Earnings Conference Call March 14, 2018 5:00 PM ETExecutivesJohn Herrmann - Senior Vice President, General Counsel & Corporate SecretaryStan Erck - . . .
Posted on 3/15/18
Vanda Pharmaceuticals Proposes Public Offering of Common Stock
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA)today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering . . .
Posted on 3/13/18
LUNGevity Joins Sustainable Healthy Communities Diverse Cancer Communities Working Group
LUNGevity is proud to announce that the Foundation is serving on three subcommittees of Sustainable Healthy Communities, LLC, founded by the National Minority Quality Forum. As . . .
Posted on 3/13/18
Supernus Proposes Private Offering of $350 Million of Convertible Senior Notes
ROCKVILLE, Md., March 13, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of . . .
Posted on 3/13/18
OpGen Announces Collaborator in Verification Study for Acuitas Test
GAITHERSBURG, Md., March 13, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) announced today that it is collaborating with Beth Israel Deaconess Medical Center (BIDMC) in Boston . . .
Posted on 3/13/18
Grotto Pizza Launching March Mania and National Pi Day Celebrations
GAMBRILLS, Md. – March comes in like a lion at Grotto Pizza with college basketball and “Pi(e)” celebrations.The March Mania festivities kick off with the College . . .
Posted on 3/12/18
RegeneRx Receives "Decision to Grant" European Patent For Treatment of Peripheral Neuropathy
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) , a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that the European Patent Office has . . .
Posted on 3/12/18
Altimmune Announces Pre-Clinical Data From its SparVax-L Anthrax Vaccine Program
GAITHERSBURG, Md., March 12, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced data from a pre-clinical study comparing SparVax-L and BioThrax® . . .
Posted on 3/12/18
Orgenesis Announces Listing on NASDAQ Capital Market
GERMANTOWN, Md., March 12, 2018 (GLOBE NEWSWIRE) -- Orgenesis Inc., (OTCQB:ORGS), a manufacturer, service provider and developer of advanced cell therapies, today announced that its common . . .
Posted on 3/12/18
Rexahn Pharmaceuticals Reports Full Year 2017 Financial Results
ROCKVILLE, Md., March 12, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of . . .
Washington DC
